Engene Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.53

+0.00 (+0.00%)

As of Oct 31, 10:26 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 10 56%

Hold 7 39%

Sell 1 6%

Price Target

Analyst Price Target +4,169.9% upside

Low Target $48.23

Average Target $65.33

High Target $96.03

Current Price $1.53

Current
$1.53

Target
$65.33

$48.23 $65.33 avg $96.03

Scenario Analysis

Bear Case

$48.23

3,052.3%

Low target

Base Case

$65.33

+4,169.9%

Avg target

Bull Case

$96.03

+6,176.5%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$12.25

-87.5% from high

52-Week Low

$1.40

+9.3% from low

Target vs 52W High

$65.33

+433.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%